← back to search

Na Jiao

North China University of Water Resources and Electric Power · CN
Area of research
Molecular Biology · Genetics
Research interest
Research interests include Gut microbiota and health, Inflammatory Bowel Disease, Rough Sets and Fuzzy Logic, and Liver Disease Diagnosis and Treatment.
h-index
19
citations
2,689
works
119
NIH funding
primary concept
email

Recent publications

Multi-kingdom microbial signatures in excess body weight colorectal cancer based on global metagenomic analysis
Communications Biology 2024cited by 19position: lastdoi
Identification and validation of microbial biomarkers from cross-cohort datasets using xMarkerFinder
Nature Protocols 2024cited by 19position: lastdoi
Systematic identification of secondary bile acid production genes in global microbiome
mSystems 2024cited by 12position: lastdoi
Microbial genes outperform species and SNVs as diagnostic markers for Crohn’s disease on multicohort fecal metagenomes empowered by artificial intelligence
Gut Microbes 2023cited by 36position: middledoi
Multimodal metagenomic analysis reveals microbial single nucleotide variants as superior biomarkers for early detection of colorectal cancer
Gut Microbes 2023cited by 30position: lastdoi
Multi-kingdom microbiota analyses identifybacterial–fungal interactions and biomarkers of colorectal cancer acrosscohorts
Nature Microbiology 2022cited by 296position: middledoi
Targeting keystone species helps restore the dysbiosis of butyrate‐producing bacteria in nonalcoholic fatty liver disease
iMeta 2022cited by 45position: middledoi
Identification of microbial markers across populations in early detection of colorectal cancer
Nature Communications 2021cited by 237position: middledoi
Gastrointestinal sequelae 90 days after discharge for COVID-19
˜The œLancet. Gastroenterology & hepatology 2021cited by 135position: middledoi
Microbiota in mesenteric adipose tissue from Crohn’s disease promote colitis in mice
Microbiome 2021cited by 52position: middledoi
Altered gut microbiome in FUT2 loss-of-function mutants in support of personalized medicine for inflammatory bowel diseases
Journal of genetics and genomics/Journal of Genetics and Genomics 2021cited by 50position: middledoi
Enteric involvement in hospitalised patients with COVID-19 outside Wuhan
˜The œLancet. Gastroenterology & hepatology 2020cited by 177position: middledoi
Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD
Gut 2017cited by 724position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Ruixin Zhu · Shanghai First Maternity and Infant Hospital11 papers (2017–2024)Lixin Zhu · Harvard University11 papers (2017–2024)Ping Lan · Sun Yat-sen University7 papers (2020–2024)Dingfeng Wu · Children's Hospital of Zhejiang University7 papers (2020–2024)Wenxing Gao · Shihezi University5 papers (2023–2024)Yichen Li · Tianjin University of Science and Technology4 papers (2020–2021)Sijing Cheng · Sun Yat-sen University4 papers (2020–2021)Liwen Tao · Shanghai First Maternity and Infant Hospital3 papers (2021–2024)Sheng Gao · Guangzhou University of Chinese Medicine3 papers (2023–2024)Yifeng Zou · Wuhan Polytechnic University3 papers (2020–2021)Yibo Huang · Nanjing Drum Tower Hospital3 papers (2020–2021)Guoqing Zhang · Fudan University2 papers (2022–2024)Wenjing Yin · Qingdao Agricultural University2 papers (2024–2024)Min Zhi · Sun Yat-sen University2 papers (2021–2021)Yida Zhang · Macau University of Science and Technology2 papers (2021–2022) · 2 papers (2023–2023)Guangjun Yan · Union Hospital2 papers (2020–2021)Chuan Tian · Oregon State University2 papers (2021–2022) · 2 papers (2024–2024)Lei Liu · Dalian Medical University2 papers (2022–2024)